Medicare Enrolled
Dr. Hanni Salih, M.D.
Medical Oncology · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Salih from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Salih?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Salih
Dr. Hanni Salih is a medical oncology specialist in San Antonio, TX, with 13 years of NPI registration. Based on federal Medicare data, Dr. Salih performed 30,785 Medicare services across 1,825 unique beneficiaries.
Between the years covered by Open Payments, Dr. Salih received a total of $11,310 from 74 pharmaceutical and/or device companies across 448 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Salih is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 30% volume in TX
$11,310 industry payments
Medicare Practice Summary
Medicare Utilization ↗30,785
Medicare services
Top 30% in TX for medical oncology
1,825
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,368 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
24,750 | $1 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,026 | $0 | $0 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
645 | $10 | $32 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
572 | $8 | $23 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
492 | $92 | $373 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
485 | $8 | $16 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
273 | $22 | $86 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
226 | $98 | $376 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
169 | $6 | $19 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
165 | $6 | $18 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
153 | $13 | $41 |
| Iron level test | 143 | $6 | $19 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
143 | $9 | $26 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
133 | $60 | $231 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
118 | $11 | $47 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
110 | $12 | $58 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
99 | $21 | $90 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
98 | $18 | $57 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
97 | $47 | $205 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
86 | $7 | $20 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
84 | $49 | $185 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
78 | $2 | $19 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 75 | $340 | $1,342 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
64 | $123 | $523 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
63 | $25 | $137 |
| CA 19-9 tumor antigen test A blood test that measures the level of CA 19-9, a substance that can be found in the blood of some people with cancer. This quantitative analysis detects and measures the specific tumor antigen. |
53 | $20 | $62 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
51 | $9 | $28 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
47 | $9 | $27 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $123 | $486 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $64 | $263 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
43 | $10 | $42 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
37 | $15 | $45 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
25 | $5 | $16 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 21 | $20 | $62 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
20 | $4 | $13 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
18 | $4 | $14 |
| New patient office visit, complex (60-74 min) | 16 | $172 | $641 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
13 | $4 | $12 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
83.1% high complexity
4.6% medium
12.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,310
Total received (2018-2024)
Avg $1,616/year across 7 years
Top 36% in TX for medical oncology
74
Companies
448
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,795 (68.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,516 (31.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,183
2023
$678
2022
$1,664
2021
$1,430
2020
$1,657
2019
$4,390
2018
$308
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$2,613
Novartis Pharmaceuticals Corporation
$660
Astellas Pharma US Inc
$563
AstraZeneca Pharmaceuticals LP
$557
E.R. Squibb & Sons, L.L.C.
$472
Amgen Inc.
$437
Janssen Biotech, Inc.
$420
Genentech USA, Inc.
$357
Incyte Corporation
$313
Daiichi Sankyo Inc.
$302
Celgene Corporation
$276
Regeneron Healthcare Solutions, Inc.
$268
PFIZER INC.
$239
Takeda Pharmaceuticals U.S.A., Inc.
$235
Eisai Inc.
$207
Rigel Pharmaceuticals, Inc.
$178
Lilly USA, LLC
$158
Kite Pharma, Inc.
$145
Seattle Genetics, Inc.
$142
Gilead Sciences, Inc.
$130
Foundation Medicine, Inc.
$117
EMD Serono, Inc.
$108
Taiho Oncology, Inc.
$108
Seagen Inc.
$107
Galvanize Therapeutics, Inc
$102
BeiGene USA, Inc.
$97
SANOFI-AVENTIS U.S. LLC
$97
AbbVie, Inc.
$91
Merck Sharp & Dohme LLC
$88
Blueprint Medicines Corporation
$85
Merck Sharp & Dohme Corporation
$85
Ipsen Biopharmaceuticals, Inc
$85
Alexion Pharmaceuticals, Inc.
$83
Karyopharm Therapeutics Inc.
$75
Dova Pharmaceuticals
$75
JAZZ PHARMACEUTICALS INC.
$72
Teva Pharmaceuticals USA, Inc.
$69
Pharmacyclics LLC, An AbbVie Company
$66
MorphoSys, US Inc.
$62
GlaxoSmithKline, LLC.
$58
Pharmacosmos Therapeutics Inc.
$54
Myovant Sciences Inc.
$50
Kyowa Kirin, Inc.
$48
AbbVie Inc.
$48
Fennec Pharmaceuticals, Inc.
$44
Genmab U.S., Inc.
$42
Heron Therapeutics, Inc.
$41
Global Blood Therapeutics, Inc.
$36
Pharmacyclics LLC, an AbbVie Company
$36
Dendreon Pharmaceuticals LLC
$33
Aveo Pharmaceuticals, Inc.
$32
Medtronic USA, Inc.
$28
AMAG Pharmaceuticals, Inc.
$28
TOLMAR Pharmaceuticals, Inc.
$26
Immunomedics, Inc.
$26
Janssen Pharmaceuticals, Inc
$25
SERVIER PHARMACEUTICALS LLC
$25
CTI BioPharma Corp.
$24
Sumitomo Pharma America, Inc.
$22
MACROGENICS, INC.
$22
PharmaEssentia USA Corporation
$21
EISAI INC.
$21
PUMA BIOTECHNOLOGY, INC.
$20
ARRAY BIOPHARMA INC
$18
TAIHO ONCOLOGY, INC.
$18
Bayer HealthCare Pharmaceuticals Inc.
$17
Puma Biotechnology, Inc.
$17
Spectrum Pharmaceuticals Inc.
$15
Jazz Pharmaceuticals Inc.
$13
TerSera Therapeutics LLC
$12
Boehringer Ingelheim Pharmaceuticals, Inc.
$12
Exelixis Inc.
$12
EUSA Pharma (US) LLC
$11
Adaptive Biotechnologies Corporation
$11
Top 3 companies account for 33.9% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALIYA SYSTEM · AYVAKIT · Abraxane · Alecensa · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRUKINSA · Bavencio · CABLIVI · CALQUENCE · CINVANTI · Cabometyx · DARZALEX · Doptelet · ELIGARD · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · FERAHEME · FOTIVDA · FOUNDATIONONE · GAVRETO · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MARGENZA · MONJUVI · MONOFERRIC · MYLOTARG · Monoferric · NERLYNX · NINLARO · Nerlynx · Nplate · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Pedmark · Perjeta · Pomalyst · REBLOZYL · ROLVEDON · Revlimid · Rituxan · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SYNCHROMED · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VOTRIENT · VYXEOS · Vanflyta · Vectibix · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Yescarta · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $37 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
37
Per 100K population
1.8
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Salih is a mixed practice specialist, with above-average Medicare volume (top 30% in TX), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Salih experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Salih performed 24,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Salih receive payments from pharmaceutical companies?
Yes. Dr. Salih received a total of $11,310 from 74 companies across 448 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Salih's costs compare to other medical oncologists in San Antonio?
Dr. Salih's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Salih) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in San Antonio
Browse medical oncologists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology